Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate

INTRODUCTION: Vitamin K antagonists (VKA) and non‐vitamin K oral antagonist anticoagulants (NOAC) are used in the clinic to reduce risk of thrombosis. However, they also exhibit vascular off‐target effects. The aim of this study is to compare VKA and NOAC on atherosclerosis progression and calcifica...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Thromb Haemost
Auteurs principaux: van Gorp, Rick H., Dijkgraaf, Ingrid, Bröker, Vanessa, Bauwens, Matthias, Leenders, Peter, Jennen, Danyel, Dweck, Marc R., Bucerius, Jan, Briedé, Jacco J., van Ryn, Joanne, Brandenburg, Vincent, Mottaghy, Felix, Spronk, Henri M. H., Reutelingsperger, Chris P., Schurgers, Leon J.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2021
Sujets:
VASCULAR BIOLOGY
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252511/
https://ncbi.nlm.nih.gov/pubmed/33687782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15289
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires